Works matching AU Sang, Xinting


Results: 81
    1
    2

    Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study.

    Published in:
    Journal of Hepatocellular Carcinoma, 2025, v. 12, p. 561, doi. 10.2147/JHC.S504016
    By:
    • Chen, Xiaokun;
    • Wu, Xiangan;
    • Peng, Wei;
    • Liu, Liguo;
    • Liu, Xiao;
    • Wan, Xueshuai;
    • Xu, Haifeng;
    • Zheng, Yongchang;
    • Zhao, Haitao;
    • Mao, Yilei;
    • Lu, Xin;
    • Sang, Xinting;
    • Chang, Xiaoyan;
    • Zhou, Kang;
    • Pan, Jie;
    • Guan, Mei;
    • Hu, Dandan;
    • Tan, Haidong;
    • Zhang, Yaojun;
    • Du, Shunda
    Publication type:
    Article
    3
    4
    5
    6

    Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2949, doi. 10.1007/s00262-023-03466-8
    By:
    • Zhu, Chengpei;
    • Li, Hu;
    • Yang, Xiaobo;
    • Wang, Shanshan;
    • Wang, Yunchao;
    • Zhang, Nan;
    • Wang, Yanyu;
    • Xue, Jingnan;
    • Zhang, Longhao;
    • Ning, Cong;
    • Yang, Xu;
    • Xun, Ziyu;
    • Chao, Jiashuo;
    • Long, Junyu;
    • Sang, Xinting;
    • Zhu, Zhenyu;
    • Zhao, Haitao
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Mps1/TTK: a novel target and biomarker for cancer.

    Published in:
    Journal of Drug Targeting, 2017, v. 25, n. 2, p. 112, doi. 10.1080/1061186X.2016.1258568
    By:
    • Xie, Yuan;
    • Wang, Anqiang;
    • Lin, Jianzhen;
    • Wu, Liangcai;
    • Zhang, Haohai;
    • Yang, Xiaobo;
    • Wan, Xueshuai;
    • Miao, Ruoyu;
    • Sang, Xinting;
    • Zhao, Haitao
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.

    Published in:
    Neuroendocrinology, 2022, v. 112, n. 3, p. 263, doi. 10.1159/000516812
    By:
    • Xu, Gang;
    • Xiao, Yao;
    • Hu, Hanjie;
    • Jin, Bao;
    • Wu, Xiang'an;
    • Wan, Xueshuai;
    • Zheng, Yongchang;
    • Xu, Haifeng;
    • Lu, Xin;
    • Sang, Xinting;
    • Ge, Penglei;
    • Mao, Yilei;
    • Cai, Jianqiang;
    • Zhao, Hong;
    • Du, Shunda
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50